These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31063852)

  • 1. GCK-MODY in the US Monogenic Diabetes Registry: Description of 27 unpublished variants.
    Sanyoura M; Letourneau L; Knight Johnson AE; Del Gaudio D; Greeley SAW; Philipson LH; Naylor RN
    Diabetes Res Clin Pract; 2019 May; 151():231-236. PubMed ID: 31063852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated.
    Carmody D; Naylor RN; Bell CD; Berry S; Montgomery JT; Tadie EC; Hwang JL; Greeley SA; Philipson LH
    Acta Diabetol; 2016 Oct; 53(5):703-8. PubMed ID: 27106716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families.
    Santana LS; Caetano LA; Costa-Riquetto AD; Quedas EPS; Nery M; Collett-Solberg P; Boguszewski MCS; Vendramini MF; Crisostomo LG; Floh FO; Zarabia ZI; Kohara SK; Guastapaglia L; Passone CGB; Sewaybricker LE; Jorge AAL; Teles MG
    Clin Genet; 2017 Oct; 92(4):388-396. PubMed ID: 28170077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry.
    Dickens LT; Letourneau LR; Sanyoura M; Greeley SAW; Philipson LH; Naylor RN
    Acta Diabetol; 2019 Apr; 56(4):405-411. PubMed ID: 30535721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
    Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
    Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
    Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
    BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
    Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
    Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel deletion mutation in the glucokinase gene from a korean man with GCK-MODY phenotype and situs inversus.
    Cho YK; Cho EH; Choi HS; Kim SW
    Diabetes Res Clin Pract; 2018 Sep; 143():263-266. PubMed ID: 30086370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial GCK gene deletion mutations causing maturity-onset diabetes of the young.
    Yu R; Zhang H; Xiao X
    Acta Diabetol; 2024 Jan; 61(1):107-115. PubMed ID: 37704826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucokinase mutations in pediatric patients with impaired fasting glucose.
    Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
    Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturity-onset diabetes of the young (MODY) in Brazil: Establishment of a national registry and appraisal of available genetic and clinical data.
    Giuffrida FMA; Moises RS; Weinert LS; Calliari LE; Manna TD; Dotto RP; Franco LF; Caetano LA; Teles MG; Lima RA; Alves C; Dib SA; Silveiro SP; Dias-da-Silva MR; Reis AF;
    Diabetes Res Clin Pract; 2017 Jan; 123():134-142. PubMed ID: 28012402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-step programmed method for the identification of causative gene mutations of maturity onset diabetes of the young (MODY).
    Li Q; Cao X; Qiu HY; Lu J; Gao R; Liu C; Yuan MX; Yang GR; Yang JK
    Gene; 2016 Aug; 588(2):141-8. PubMed ID: 27185633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Confirmation Rate in Clinically Suspected Maturity-Onset Diabetes of the Young.
    Brahm AJ; Wang G; Wang J; McIntyre AD; Cao H; Ban MR; Hegele RA
    Can J Diabetes; 2016 Dec; 40(6):555-560. PubMed ID: 27634015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY.
    Weinert LS; Silveiro SP; Giuffrida FM; Cunha VT; Bulcão C; Calliari LE; Della Manna T; Kunii IS; Dotto RP; Dias-da-Silva MR; Reis AF
    Diabetes Res Clin Pract; 2014 Nov; 106(2):e44-8. PubMed ID: 25174781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations.
    Pruhova S; Dusatkova P; Sumnik Z; Kolouskova S; Pedersen O; Hansen T; Cinek O; Lebl J
    Pediatr Diabetes; 2010 Dec; 11(8):529-35. PubMed ID: 20337973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.
    Johansen A; Ek J; Mortensen HB; Pedersen O; Hansen T
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4607-14. PubMed ID: 15928245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-fold increased prevalence of rare glucokinase gene variant carriers in unselected Danish patients with newly diagnosed type 2 diabetes.
    Gjesing AP; Engelbrechtsen L; Cathrine B Thuesen A; Have CT; Hollensted M; Grarup N; Linneberg A; Steen Nielsen J; Christensen LB; Thomsen RW; Johansson KE; Cagiada M; Gersing S; Hartmann-Petersen R; Lindorff-Larsen K; Vaag A; Sørensen HT; Brandslund I; Beck-Nielsen H; Pedersen O; Rungby J; Hansen T
    Diabetes Res Clin Pract; 2022 Dec; 194():110159. PubMed ID: 36400171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the GCK gene in 79 MODY type 2 patients: A multicenter Turkish study, mutation profile and description of twenty novel mutations.
    Aykut A; Karaca E; Onay H; Gökşen D; Çetinkalp Ş; Eren E; Ersoy B; Çakır EP; Büyükinan M; Kara C; Anık A; Kırel B; Özen S; Atik T; Darcan Ş; Özkınay F
    Gene; 2018 Jan; 641():186-189. PubMed ID: 29056535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based estimates for double diabetes amongst people with glucokinase monogenic diabetes, GCK-MODY.
    Fendler W; Małachowska B; Baranowska-Jazwiecka A; Borowiec M; Wyka K; Malecki MT; Jarosz-Chobot P; Mysliwiec M; Mlynarski W;
    Diabet Med; 2014 Jul; 31(7):881-3. PubMed ID: 24660669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.